Anti-Axl antibody [EPR21107]
- KO Validated
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
2
(2 Reviews)
|
(15 Publications)
Rabbit Recombinant Monoclonal Axl antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 15 publications.
View Alternative Names
UFO, AXL, Tyrosine-protein kinase receptor UFO, AXL oncogene
- WB
Supplier Data
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Exposure time : Lane 1 : 6 seconds; Lane 2 : 3 seconds; Lane 3 : 46 seconds; Lanes 4-5 : 3 minutes; Lanes 6-7 : 10 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
The 140 kDa band corresponds to the full-length Axl, while the 80 kDa band could be the cleaved form of Axl (PMID : 7822279 and 19541935).
The apparent molecular mass is higher than predicted, likely due to glycosylation (PMID : 23629654).
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Human skeletal muscle lysate at 20 µg
Lane 2:
Rat muscle lysate at 10 µg
Lane 3:
Mouse muscle lysate at 10 µg
Lane 4:
4T1 (mouse mammary gland carcinoma cell line) whole cell lysate at 20 µg
Lane 5:
C2C12 (mouse myoblast cell line) whole cell lysate at 20 µg
Lane 6:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 7:
HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 98 kDa
Observed band size: 140 kDa,80 kDa
true
- WB
Lab
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Lanes 1 - 4 : Merged signal (red and green). Green - ab215205 observed at 135 kDa. Red - loading control, ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab215205 was shown to react with Axl in western blot. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab215205 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 40 µg
Lane 2:
AXL knockout HeLa cell lysate at 40 µg
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
AXL knockout HeLa cell lysate at 20 µg
Predicted band size: 98 kDa
Observed band size: 135 kDa
false
- WB
Unknown
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Western blot : Anti-Axl antibody [EPR21107] (ab215205) staining at 1 : 1000 dilution, shown in green; Anti-GAPDH antibody [6C5] - Loading Control (ab8245) shown in red.
ab215205 was shown to bind specifically to Axl. A band was observed at 140 kDa in wild-type HeLa cell lysates with no signal observed at this size in Axl CRISPR-Cas9 edited cell line ab261810 (CRISPR-Cas9 edited cell lysate ab257151). The band observed in the CRISPR-Cas9 edited lysate lane below 90 kDa is likely to represent a truncated form of Axl. This has not been investigated further and the functional properties of the gene product have not been determined.
Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/10000 dilution.
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human AXL knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-axl-knockout-hela-cell-line-ab261810'>ab261810</a>)
Lane 2:
Western blot - Human AXL knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-axl-knockout-hela-cell-lysate-ab257151'>ab257151</a>)
Lane 2:
AXL knockout HeLa cell lysate at 20 µg
Lane 3:
NCI-H1299 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 98 kDa
Observed band size: 80140 kDa
false
- WB
Supplier Data
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Blocking/Dilution buffer : 5% NFDM/TBST.
Negative control : JurkatThe 140 kDa band corresponds to the full-length Axl, while the 80 kDa band could be the cleaved form of Axl (PMID : 7822279 and 19541935).
The apparent molecular mass is higher than predicted, likely due to glycosylation (PMID : 23629654).
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
DU 145 (human prostate carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
NCI-H1299 (human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 98 kDa
Observed band size: 140 kDa,80 kDa
true
Exposure time: 29s
- WB
Lab
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Western blot : Anti-Axl antibody [EPR21107] (ab215205) staining at 1 : 1000 dilution, shown in green; Anti-GAPDH antibody [6C5] - Loading Control (ab8245) shown in red.
ab215205 was shown to bind specifically to Axl. A band was observed at 140 kDa in wild-type HeLa cell lysates with no signal observed at this size in Axl CRISPR-Cas9 edited cell line ab265392 (CRISPR-Cas9 edited cell lysate ab257152). The band observed in the CRISPR-Cas9 edited lysate lane below 90 kDa is likely to represent a truncated form of Axl. This has not been investigated further and the functional properties of the gene product have not been determined.
Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/10000 dilution.
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
AXL knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human AXL knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-axl-knockout-hela-cell-line-ab265392'>ab265392</a>)
Lane 2:
Western blot - Human AXL knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-axl-knockout-hela-cell-lysate-ab257152'>ab257152</a>)
Lane 3:
NCI-H1299 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 98 kDa
Observed band size: 80140 kDa
false
- WB
Lab
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Western blot : Anti-Axl antibody [EPR21107] (ab215205) staining at 1 : 1000 dilution, shown in green; Anti-GAPDH antibody [6C5] - Loading Control (ab8245) shown in red.
ab215205 was shown to bind specifically to Axl. A band was observed at 140 kDa in wild-type HeLa cell lysates with no signal observed at this size in Axl CRISPR-Cas9 edited cell line ab261810 (CRISPR-Cas9 edited cell lysate ab257151). The band observed in the CRISPR-Cas9 edited lysate lane below 90 kDa is likely to represent a truncated form of Axl. This has not been investigated further and the functional properties of the gene product have not been determined.
Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/10000 dilution.
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
AXL knockout HeLa cell lysate at 20 µg
Lane 3:
NCI-H1299 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 98 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
False colour image of Western blot : Anti-Axl antibody [EPR21107] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab215205 was shown to bind specifically to Axl. A band was observed at 135 kDa in wild-type A549 cell lysates with no signal observed at this size in AXL knockout cell line ab273744 (knockout cell lysate ab273780). To generate this image, wild-type and AXL knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
AXL knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human AXL knockout A549 cell line (<a href='/en-us/products/cell-lines/human-axl-knockout-a549-cell-line-ab273744'>ab273744</a>)
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 98 kDa
Observed band size: 135 kDa
false
- WB
Lab
Western blot - Anti-Axl antibody [EPR21107] (AB215205)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
ab219651 exhibits low sensitivity in western blot. It is recommended to use ab259831 or ab215205 as alternatives or to optimize experimental conditions by increasing the sample loading amount, using a lower antibody dilution ratio, and employing femtogram-level sensitivity substrates.
Lanes 1 - 3:
Western blot - Anti-Axl antibody [EPR19880] (<a href='/en-us/products/primary-antibodies/axl-antibody-epr19880-ab219651'>ab219651</a>) at 1/1000 dilution
Lanes 5 - 7:
Western blot - Anti-Axl antibody [EPR23892-15] (<a href='/en-us/products/primary-antibodies/axl-antibody-epr23892-15-ab259831'>ab259831</a>) at 1/1000 dilution
Lanes 9 - 11:
Western blot - Anti-Axl antibody [EPR21107] (ab215205) at 1/1000 dilution
Lanes 1, 5 and 9:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 20 µg
Lanes 2, 6 and 9:
HUVEC (human umbilical vein endothelial cell line) whole cell lysate 20 µg
Lanes 3, 7 and 11:
A549 (Human lung carcinoma epithelial cell) whole cell lysate 20 µg
Lanes 4, 8 and 12:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 98 kDa
Observed band size: 80 kDa,140 kDa
false
Exposure time: 180s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Axl is important in mediating cell survival proliferation and migration. It functions as part of the TAM family of receptors which also includes Tyro3 and Mer. Axl often forms complexes with these receptors to facilitate efficient signaling. This interaction triggers phosphorylation events that activate downstream signaling proteins reinforcing its influence in cellular functions.
Pathways
Axl is deeply involved in the PI3K-Akt and MAPK signaling pathways which are central to cellular growth and survival. In these pathways Axl interacts closely with proteins like PI3K and Akt to regulate processes such as apoptosis and metabolism. Its interaction with these pathways places Axl as an important modulator of intracellular signaling cascades.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Cancer biology & therapy 26:2558402 PubMed40947978
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 44:11 PubMed39794830
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed39774471
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:623 PubMed39187498
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14742 PubMed38715283
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 26:448 PubMed37614420
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4162 PubMed37443109
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 9:2 PubMed36609376
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmacologica Sinica 44:984-998 PubMed36450791
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 22:179-191 PubMed36399631
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com